IL6 and rheumatoid arthritis: Therapeutic interventions such as T cell co-stimulation signaling blockades, inhibition of pro-inflammatory cytokines (Tumor Necrosis factor-α (TNFα) and Interleukin-6 (IL-6)), and B cell depletion, reveal that RA is a disorder that has numerous root causes.